SGS is a CRO providing clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. Delivering solutions in Europe and in Americas, SGS offers clinical trial (Phase I to IV) services encompassing early phase drug development consultancy, clinical monitoring, biometrics and regulatory & medical affairs services. SGS has its own clinical unit in Belgium including a Human challenge testing facility and two phase I patients units based in Belgium and Hungary.
SGS has a wealth of expertise in FIH studies, viral challenge testing, and complex PK/PD studies with a high therapeutic focus in Infectious Diseases, Vaccines, and Respiratory.
